Panel backs tobramycin inhalation powder

FDA's Anti-Infective Drugs Advisory Committee voted 13-1 that Novartis AG (NYSE:NVS; SIX:NOVN) demonstrated adequate evidence of

Read the full 161 word article

User Sign In